TickerFacts.

Polyrizon Ltd. (PLRZ): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$4.53M
Year ended 2025-12-31
2022-12-31: -$1.13M2023-12-31: -$537.0K2024-12-31: -$1.15M2025-12-31: -$4.53M-$4.53M
2022-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$4.53Mn/m2026-03-25, From 2025-01-01
2024-12-31-$1.15Mn/m2026-03-25, From 2024-01-01
2023-12-31-$537.0Kn/m2026-03-25, From 2023-01-01
2022-12-31-$1.13Mn/a2025-03-11, From 2022-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Polyrizon Ltd. (PLRZ)2025-12-31-$4.53Mn/m
Spectral AI, Inc. (MDAI)2025-12-31-$9.92Mn/m
Femasys Inc (FEMY)2025-12-31-$18.69Mn/m
PolyPid Ltd. (PYPD)2025-12-31-$27.88Mn/m
Picard Medical, Inc. (PMI)2025-12-31-$15.67Mn/m
INVO Fertility, Inc. (IVF)2025-12-31-$7.01Mn/m
Co-Diagnostics, Inc. (CODX)2025-12-31-$29.14Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$15.26Mn/m
Cerenome, Inc. (CNSY)2025-12-31-$20.77Mn/m

Compare PLRZ, MDAI, FEMY, PYPD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗